BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 32188810)

  • 1. Accelerated Phase of Atypical Chronic Myeloid Leukemia with Severe Disseminated Intravascular Coagulation at Initial Presentation.
    Fujita M; Kamachi K; Yokoo M; Kidoguchi K; Kusaba K; Kizuka-Sano H; Yamaguchi K; Nishioka A; Yoshimura M; Kubota Y; Ando T; Kojima K; Kimura S
    Intern Med; 2020 Jun; 59(12):1549-1553. PubMed ID: 32188810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical chronic myeloid leukemia is clinically distinct from unclassifiable myelodysplastic/myeloproliferative neoplasms.
    Wang SA; Hasserjian RP; Fox PS; Rogers HJ; Geyer JT; Chabot-Richards D; Weinzierl E; Hatem J; Jaso J; Kanagal-Shamanna R; Stingo FC; Patel KP; Mehrotra M; Bueso-Ramos C; Young KH; Dinardo CD; Verstovsek S; Tiu RV; Bagg A; Hsi ED; Arber DA; Foucar K; Luthra R; Orazi A
    Blood; 2014 Apr; 123(17):2645-51. PubMed ID: 24627528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, in a 5-Month Baby - ARare Presentation.
    Saqlain N; Ahmed N
    J Coll Physicians Surg Pak; 2016 Nov; 26(11):103-105. PubMed ID: 28666496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How I treat atypical chronic myeloid leukemia.
    Gotlib J
    Blood; 2017 Feb; 129(7):838-845. PubMed ID: 27899359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blast crisis accompanied by severe DIC of Ph negative chronic myeloid leukemia showing t(9;16) and positive M-BCR/ABL rearrangement].
    Fujiwara H; Takahashi N; Tada J; Higuchi T; Harada H; Mori H; Niikura H; Omine M; Fujita K
    Rinsho Ketsueki; 1997 Aug; 38(8):663-68. PubMed ID: 9311272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Chronic Myeloid Leukemia: Where Are We Now?
    Crisà E; Nicolosi M; Ferri V; Favini C; Gaidano G; Patriarca A
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Exercise in Extrapolation: Clinical Management of Atypical CML, MDS/MPN-Unclassifiable, and MDS/MPN-RS-T.
    Talati C; Padron E
    Curr Hematol Malig Rep; 2016 Dec; 11(6):425-433. PubMed ID: 27664113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transformation of secondary myelodysplastic syndrome to atypical chronic myeloid leukemia in a female patient with acute myeloid leukemia].
    Gritsaev SV; Kostroma II; Zapreev IM; Shmidt AV; Tiranova SA; Balashova VA; Martynkevich IS; Chubukina ZV; Semenova NY; Chechetkin AV
    Ter Arkh; 2016; 88(7):104-108. PubMed ID: 27459623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
    Elsayed M; Harry S; Nanua S; Zaidi S; Habib MH; Raza S
    Cureus; 2022 Jul; 14(7):e26619. PubMed ID: 35949766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical chronic myeloid leukemia as defined in the WHO classification is a JAK2 V617F negative neoplasm.
    Fend F; Horn T; Koch I; Vela T; Orazi A
    Leuk Res; 2008 Dec; 32(12):1931-5. PubMed ID: 18555525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical Chronic Myeloid Leukemia: New Developments from Molecular Diagnosis to Treatment.
    Castellino A; Santambrogio E; Rapezzi D; Massaia M
    Medicina (Kaunas); 2021 Oct; 57(10):. PubMed ID: 34684141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical Chronic Myeloid Leukemia in Two Pediatric Patients.
    Freedman JL; Desai AV; Bailey LC; Aplenc R; Burnworth B; Zehentner BK; Teachey DT; Wertheim G
    Pediatr Blood Cancer; 2016 Jan; 63(1):156-9. PubMed ID: 26274939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current and evolving understanding of atypical chronic myeloid leukemia.
    Schwartz LC; Mascarenhas J
    Blood Rev; 2019 Jan; 33():74-81. PubMed ID: 30078497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCR-ABL1 negative chronic myeloid leukemia: report of two cases].
    Figueroa-Faúndez F; Vidal-Rojas C; Briones-Muñoz V; Chandía-Cabas M
    Rev Med Chil; 2022 Mar; 150(3):397-401. PubMed ID: 36156725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
    Kvasnicka HM
    Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelodysplastic/myeloproliferative neoplasm with neutrophilia (atypical chronic myeloid leukemia-aCML).
    Martino G; Quintini M; Martelli MP; Ascani S; Lazzi S; Mecucci C
    Am J Hematol; 2023 Jul; 98(7):1163-1164. PubMed ID: 36594191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atypical chronic myeloid leukaemia with trisomy 13: a case report.
    Guo-yu H; Chao-hui Y; Kui T; Zhen-zhen C
    Chin Med Sci J; 2011 Dec; 26(4):254-6. PubMed ID: 22218057
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transformation from atypical chronic myeloid leukemia to chronic myelomonocytic leukemia as progression of myeloid neoplasm with platelet-derived growth factor ß rearrangement.
    Shi X; Su Z; Zhao C; Feng X
    J Cancer Res Ther; 2015; 11(4):914-6. PubMed ID: 26881541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation for the treatment of BCR-ABL1-negative atypical chronic myeloid leukemia and chronic neutrophil leukemia: A retrospective nationwide study in Japan.
    Itonaga H; Ota S; Ikeda T; Taji H; Amano I; Hasegawa Y; Ichinohe T; Fukuda T; Atsuta Y; Tanizawa A; Kondo T; Miyazaki Y
    Leuk Res; 2018 Dec; 75():50-57. PubMed ID: 30458320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.